How Industry 4.0 is driving pharma manufacturing
Patient safety is an Industry 4.0 technology driver, by aggregating real-time data and transfer it to a centralised data hub, monitored regularly to...
Neues Technikum stärkt Standort von Covestro in NRW
20 Millionen Euro Investition Neues Technikum stärkt Standort von Covestro in NRW Am 5. März 2024 hat Covestro im Chempark Leverkusen sein neues,...
Quality and Efficiency in Pharma Manufacturing
The pharmaceutical industry is confronting a variety of new and complex challenges in the face of globalization and changing market dynamics. The...
Forschung bei Boehringer Ingelheim: KI entwickelt Antikörper
Bei der Forschung nach neuen therapeutischen Antikörpern setzt Boehringer Ingelheim auf die Unterstützung durch KI. Foto: Corona Borealis Studio -...
GSK completes acquisition of Aiolos Bio
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company...
Boehringer Ingelheim Biologicals Development Centre Biberach
Boehringer Ingelheim is developing a biologicals development centre (BDC) at its facility in Biberach, Germany. Credit: Boehringer Ingelheim. A...
Boehringer Ingelheim geht Partnerschaft mit Veeva ein, um seine…
Weltweit führendes Unternehmen der Tiermedizin führt Veeva Vault Clinical und Veeva Vault RIM für mehr Effizienz, Transparenz und Geschwindigkeit...
Effizienz durch Engineering in den Anfangsphasen
Effizienz durch Engineering in den Anfangsphasen Die biotechnologische Produktion vom Labor auf industriellen Maßstab zu bringen, ist eine...
GSK and Elegen Team Up to Develop DNA-Based Medicines
When Matt Hill, PhD, was in graduate school, the human genome sequence was more or less finished and companies like 454 and Solexa were starting to...
European Commission authorises GSK’s Omjjara (momelotinib)
Omjjara is the first medicine in the EU specifically indicated for treating splenomegaly (enlarged spleen) or symptoms in adult myelofibrosis...